French biopharmaceutical company of the Ipsen group headquartered in Paris, holding marketing authorizations for specialty medicines in oncology, rare diseases and neuroscience, such as Somatuline, Decapeptyl, Dysport and Cabometyx.
No comments available.
Leave your rating & comment